Irving
Irving is pursuing his MD at Harvard Medical School, where he was awarded the Dean's REACH Scholarship. He seeks to merge his passion for neuroscience and advocacy to increase access to behavioral healthcare in underserved populations.
Siva
A first-generation US college student, Siva studied Mathematics and Molecular/Cellular Biology at Harvard College, graduating in three years with highest honors in field and Phi Beta Kappa distinction. He is now a MD candidate at Harvard Medical School.
Winston L.
Winston is an MD Candidate at Harvard Medical School. Previously, he pursued an undergraduate degree in Molecular Biology at Princeton University, where he graduated magna cum laude.
Nic
Nic found graduated from Princeton University in 2018 with a degree in Molecular Biology and Creative Writing, cum laude. Then, Nic completed a research year at Princeton Neuroscience Institute prior to starting at Harvard Medical School, where they are currently an MD candidate. They have received Harvard’s Presidential Public Service Scholarship and the REACH Scholarship.
Ellen Z.
Ellen is a MD candidate at Harvard Medical School, where she is Editor-In-Chief of the Harvard Medical Student Review and Executive Director of the student-run free clinic. She studied life sciences and creative writing at Harvard College. Currently, she serves as a Harvard non-resident tutor and Harvard Alumni interviewer.
Jalen
A Florida native, Jalen traded sunshine for scholastics and is now an MD and MPP Candidate at Harvard Medical School and Harvard Kennedy School respectively. He spent his undergrad at Dartmouth College where he majored in Ecology.
Olivia B.
Olivia attended the University of Rochester, studying Neuroscience and American Sign Language. She's pursuing her MD at Harvard Medical School, where she’s exploring her interests in pediatrics and neonatology.
Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Rhea T.
Rhea majored in Molecular, Cellular and Developmental Biology at Yale University, where she completed her thesis research on studying the effects of m6A RNA modifications on blood system development and leukemia. She is currently an MD candidate at Harvard Medical School in the Pathways Program and is passionate about improving mental health care and resources.
Ryan R.
Ryan graduated from Yale College with honors in Molecular, Cellular, and Developmental Biology, and completed the Multidisciplinary Academic Program in Global Health. He is currently a student at Harvard Medical School, and hopes to pursue a career in infectious diseases.